| Related Articles |
Virus, vessel, victory: a novel approach to tumor killing.
Clin Cancer Res. 2018 Dec 10;:
Authors: Bykov Y, Zamarin D
Abstract
Ovarian cancer is intimately dependent on aberrant tumor vasculature. A unique therapeutic approach combining a systemic oncolytic virus with a novel vascular-normalizing agent in ovarian cancer demonstrates the potential to enhance anti-tumor efficacy through improved delivery of the virus and enhanced infiltration of immune cells into the tumors.
PMID: 30530816 [PubMed - as supplied by publisher]
from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2SD4g8c
No comments:
Post a Comment